Oral Delivery of Biologics via the Intestine
Biologics are currently one of the most promising avenues for therapeutic interventions in conditions such as metabolic disease, ageing and inflammatory disorders, and for chronic ailments, oral delivery of such medicines has for years been recognised as an important goal. Despite decades of intensi...
Main Author: | Roger New |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/1/18 |
Similar Items
-
Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid
by: Chen Z, et al.
Published: (2020-07-01) -
Long‐term daily oral administration of intestinal permeation enhancers is safe and effective in mice
by: Katherine C. Fein, et al.
Published: (2023-01-01) -
Recent Progress in the Oral Delivery of Therapeutic Peptides and Proteins: Overview of Pharmaceutical Strategies to Overcome Absorption Hurdles
by: Sonal Mehrotra, et al.
Published: (2024-03-01) -
Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update
by: Sam Maher, et al.
Published: (2019-01-01) -
Eudragit® L100/N-Trimethylchitosan Chloride Microspheres for Oral Insulin Delivery
by: Jan Steenekamp, et al.
Published: (2013-06-01)